Literature DB >> 28905162

Quality of prescribing in community-dwelling elderly patients in France: an observational study in community pharmacies.

E Bourcier1,2,3, F Mille4, V Brunie5,6, V Korb-Savoldelli5,7, C Lafortune5, M Buyse5,4, C Fernandez5,4,8, P Hindlet5,4,8.   

Abstract

Background In order to ensure safer prescriptions in the elderly, lists of potentially inappropriate medications (PIMs) and guidelines have been introduced. Whereas the effectiveness of these measures has been well studied in hospitals, data are sparse for the community-dwelling patients. Objective To assess the quality of prescriptions among community-dwelling elderly patients, and potential associations between prescription patterns, patient characteristics and medication adherence. Setting Community pharmacies in France. Method We conducted a prospective observational study between January and June 2013. Patients aged 75 and over coming to the community pharmacy with a prescription from a general practitioner were invited to participate to the study. The compliance of the prescription was assessed with regards to Beers Criteria and French Health Authority guidelines (FHA) for prescription in the elderly, the degree of adherence was assessed with the Girerd score. Main outcome measure Percentage of prescriptions compliant with Beers Criteria and FHA guidelines. Results Among the 1206 prescriptions analysed, 67.49% (n = 814) contained a PIM. Only 12.77% (n = 154) complied with mandatory requirements of the FHA. Prescriptions were ordered by therapeutic field in 51.24% (n = 618) of cases. Dosing regimen was incomplete in 57.21% (n = 690) of prescriptions. Only 29.19% (n = 352) of patients reported no difficulty with regard to adherence (Girerd score = 0). The use of International Non-proprietary Name was associated with an increased risk of nonadherence (adjusted OR = 1.59 [95% CI = 1.13-2.23] and 1.68 [95% CI = 1.12-2.49] respectively). Patient satisfaction with formulation was associated with a lower risk of non-adherence (adjusted OR = 0.63 [95% CI = 0.45-0.90]). Conclusion A substantial proportion of patients are exposed to PIMs and prescriptions that do not comply with the FHA Guidelines. This issue, as well as identified risk factors for non-adherence, should be taken into consideration by general practitioners and community pharmacists when prescribing/dispensing medications to the elderly.

Entities:  

Keywords:  Aged; Community pharmacy; Drug utilization review; France; Medication adherence; Potentially inappropriate medication

Mesh:

Year:  2017        PMID: 28905162     DOI: 10.1007/s11096-017-0531-6

Source DB:  PubMed          Journal:  Int J Clin Pharm


  35 in total

1.  American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2015-10-08       Impact factor: 5.562

2.  Attitudes of physicians and pharmacists towards International Non-proprietary Name prescribing in Belgium.

Authors:  Elien Van Bever; Monique Elseviers; Marijke Plovie; Lieselot Vandeputte; Luc Van Bortel; Robert Vander Stichele
Journal:  Basic Clin Pharmacol Toxicol       Date:  2014-10-09       Impact factor: 4.080

3.  Executive function, working memory, and medication adherence among older adults.

Authors:  Kathleen Insel; Daniel Morrow; Barbara Brewer; Aurelio Figueredo
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2006-03       Impact factor: 4.077

4.  Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes.

Authors:  Danijela Gnjidic; Sarah N Hilmer; Fiona M Blyth; Vasi Naganathan; Louise Waite; Markus J Seibel; Andrew J McLachlan; Robert G Cumming; David J Handelsman; David G Le Couteur
Journal:  J Clin Epidemiol       Date:  2012-06-27       Impact factor: 6.437

5.  Potentially inappropriate medicines in a cohort of community-dwelling older people in New Zealand.

Authors:  Prasad S Nishtala; Michael L Bagge; A John Campbell; June M Tordoff
Journal:  Geriatr Gerontol Int       Date:  2013-03-26       Impact factor: 2.730

6.  Opportunities to reduce medication regimen complexity: a retrospective analysis of patients discharged from a university hospital in Germany.

Authors:  Diana Witticke; Hanna M Seidling; Kristina Lohmann; Alexander F J Send; Walter E Haefeli
Journal:  Drug Saf       Date:  2013-01       Impact factor: 5.606

Review 7.  Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review.

Authors:  Eline Tommelein; Els Mehuys; Mirko Petrovic; Annemie Somers; Pieter Colin; Koen Boussery
Journal:  Eur J Clin Pharmacol       Date:  2015-09-26       Impact factor: 2.953

Review 8.  Inappropriate medication use among the elderly: a systematic review of administrative databases.

Authors:  Lusiele Guaraldo; Fabíola G Cano; Glauciene S Damasceno; Suely Rozenfeld
Journal:  BMC Geriatr       Date:  2011-11-30       Impact factor: 3.921

9.  Predictors of Difficulty in Medication Intake in Europe: a Cross-country Analysis Based on SHARE.

Authors:  Daniela Figueiredo; Laetitia Teixeira; Veronica Poveda; Constança Paúl; Alice Santos-Silva; Elísio Costa
Journal:  Aging Dis       Date:  2016-05-27       Impact factor: 6.745

10.  Determinants of patient adherence: a review of systematic reviews.

Authors:  Przemyslaw Kardas; Pawel Lewek; Michal Matyjaszczyk
Journal:  Front Pharmacol       Date:  2013-07-25       Impact factor: 5.810

View more
  2 in total

1.  Burden of Inappropriate Prescription of Direct Oral Anticoagulants at Hospital Admission and Discharge in the Elderly: A Prospective Observational Multicenter Study.

Authors:  Antoine Bruneau; Camille Schwab; Maud Anfosso; Christine Fernandez; Patrick Hindlet
Journal:  Drugs Aging       Date:  2019-11       Impact factor: 3.923

2.  Factors associated with medication adherence in older patients: A systematic review.

Authors:  Ashley Smaje; Maryse Weston-Clark; Ranjana Raj; Mine Orlu; Daniel Davis; Mark Rawle
Journal:  Aging Med (Milton)       Date:  2018-11-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.